The increasing adoption of advanced therapies, growing investments in biotechnology research, and rising demand for specialized manufacturing services are significantly accelerating the growth of the North America Cell and Gene Therapy Contract Development and Manufacturing Organization Market. Pharmaceutical and biotechnology companies are increasingly outsourcing development and manufacturing...

According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...